Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 531 of 1,261
  1. US 10137131

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  2. US 10138486

    Inhibitors of DEK protein and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  3. US 10138483

    Transferrin/transferrin receptor-mediated siRNA delivery

    Arrowhead Pharmaceuticals, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  4. US 10138279

    Compositions and methods for Bacillus anthracis vaccination

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  5. US 10138291

    Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  6. US 10138272

    Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  7. US 10137133

    Methods for treatment of diseases

    Galera Labs, LLC · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  8. US 10137100

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  9. US 10137104

    Combination therapy with an anti-hyaluronan agent and therapeutic agent

    HALOZYME, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  10. US 10137184

    Scaffolds for cell transplantation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  11. US 10137299

    Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects

    The Regents of the University of California · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  12. US 10138271

    Native and agonist CTL epitopes of the MUC1 tumor antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  13. US 10138298

    Anti-IL-2 antibodies and compositions and uses thereof

    The Regents of the University of California · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  14. US 10137212

    Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  15. US 10131701

    Human leucine zipper/trail recombinant polypeptides

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  16. US 10130705

    Vaccines with interleukin-33 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  17. US 10130700

    Polyvalent influenza virus-like particles (VLPS) and use as vaccines

    The United States of America, as represented by the Secretary, DHHS · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  18. US 10130651

    RNAi Therapy for Hepatitis B Virus Infection

    Arrowhead Pharmaceuticals, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  19. US 10130642

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  20. US 10130618

    Pharmaceutical combinations of dabigatran and proton pump inhibitors

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  21. US 10130594

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  22. US 10131880

    Pluripotent human adipose adult stem cells: isolation, characterization and clinical implications

    The Regents of the University of California · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  23. US 10131653

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  24. US 10132810

    Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor

    Nektar Therapeutics · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.